↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.8MSold on the market
1Companies
Sep 17, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 202621:33 | Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | EVP, Head of R&D & CMO | S · Sell10b5-1 | $62.34 | −44,674 | 100,491 | -31% | −$2.8M | ||
| Sep 17, 202621:33 | Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | EVP, Head of R&D & CMO | M · Exercise10b5-1 | $8.93 | +32,395 | 145,165 | +29% | $289K |